Kitahori Y, Naito H, Konishi N, Ohnishi T, Shirai T, Hiasa Y
Second Department of Pathology, Nara Medical University, Japan.
Cancer Lett. 1995 Sep 25;96(2):155-61. doi: 10.1016/0304-3835(95)03932-m.
N-Bis (2-hydroxypropyl) nitrosamine (DHPN) is a very potent mutagen and wide spectrum carcinogen in rodents. In the present study, we investigated mutational activation of the Ki-ras gene in eight thyroid, five kidney (four mesenchymal and one transitional cell lesion) and two lung tumors induced with DHPN. Mutations were identified using single-strand conformation polymorphism, restriction fragment length polymorphism and DNA sequencing analysis. All of the 15 neoplasms could be shown to have mutations in codon 12 (GGT-->GAT). These results suggest that Ki-ras mutations are frequent events during the development of DHPN-induced carcinomas in these organs. In a separate experiment, moreover, we analyzed the presence of Ki-ras mutations in various tissues 8 weeks after DHPN treatment. One of five thyroid tissues treated with DHPN was found to have the same characteristic mutation, suggesting that it may represent an early event during carcinogen-induced tumor formation in the thyroid.
N-双(2-羟丙基)亚硝胺(DHPN)是一种在啮齿动物中具有很强致突变性和广谱致癌性的物质。在本研究中,我们调查了用DHPN诱导的8个甲状腺肿瘤、5个肾脏肿瘤(4个间叶性和1个移行细胞病变)以及2个肺部肿瘤中Ki-ras基因的突变激活情况。通过单链构象多态性、限制性片段长度多态性和DNA测序分析来鉴定突变。15个肿瘤均显示在第12密码子存在突变(GGT→GAT)。这些结果表明,在这些器官中DHPN诱导的癌发生过程中,Ki-ras突变是常见事件。此外,在另一个实验中,我们分析了DHPN处理8周后各种组织中Ki-ras突变的情况。发现用DHPN处理的5个甲状腺组织中有1个具有相同的特征性突变,这表明它可能是致癌物诱导甲状腺肿瘤形成过程中的早期事件。